The relative bioavailability of CyA HP50 and CyA HP55 nanoparticles calculated by the AUC 0-72 were 82 3% and 119 6%, bioequivalent to the reference of Neoral.

• 与Neoral相比 ,CyA HP5 0NP与CyA HP5 5NP的相对生物利用度分别为 82 3%25和 1 1 9 6%25 ,均无显著性差异 ;